A previously undetected BaciUus subtilis aspartokinase isozyme, which we have called aspartokinase III, has been characterized. The new isozyme was most readily detected in extracts of cells grown with lysine, which repressed aspartokinase II and induced aspartokinase III, or in extracts of strain VS11, a mutant lacking aspartokinase II. Antibodies against aspartokinase II did not cross-react with aspartokinase III. Aspartokinases II and III coeluted on gel Miftration chromatography at Mr 120,000, which accounts for the previous inability to detect it. Aspartokinase III was induced by lysine and repressed by threonine. It was synergistically inhibited by lysine and threonine. Aspartokinase Im activity, like aspartokinase II activity, declined rapidly in B. subtilis cells that were starved for glucose. In contrast, the specific activity of aspartokinase I, the diaminopimelic acid-inhibitable isozyme, was constant under all growth conditions examined.
Aspartokinase (EC 2.7.2.4) catalyzes the first step of a highly branched biosynthetic sequence leading to the amino acids lysine, threonine, methionine, and isoleucine (6, 21) . An intermediate of the lysine-biosynthetic branch, mesodiaminopimelate, is also a component of the peptidoglycan of the cell wall of Bacillus species (20) . The appropriate regulation of aspartokinase activity in bacteria is usually achieved by production of multiple aspartokinase isozymes which are subject to differential regulation by end product repression and allosteric inhibition (6, 16) . In fact, the discovery and characterization of three aspartokinases in Escherichia coli provided the first clear demonstration of the physiological function of isozymes (6, 15, 21) .
Bacillus subtilis has been reported to produce two aspartokinases, which are separable by gel filtration chromatography (8, 20) . Aspartokinase I is selectively inhibited by diaminopimelate, and aspartokinase II is selectively inhibited by lysine (20) . Aspartokinase II has been purified to homogeneity from an overproducing strain (14) , and the gene encoding the enzyme has been cloned and sequenced (3) . Although partially purified aspartokinase II from B. subtilis ATCC 6051 was inhibited by both threonine and lysine (20) , the purified enzyme from a derivative of B. subtilis 168 was sensitive to lysine only (3, 14) . Aspartokinase I activity remained relatively constant throughout the growth and stationary phases in B. subtilis cells, but aspartokinase II activity disappeared rapidly during the stationary phase (20) . Because of a long-standing interest in the inactivation and degradation of enzymes in B. subtilis (22, 24) , we undertook a study of aspartokinase II degradation. In the course of these studies, several puzzling observations led us to reexamine the aspartokinases of B. subtilis. We report here the discovery of a new aspartokinase, aspartokinase III, which has previously evaded detection because it comigrates with aspartokinase II on gel filtration chromatography. The new isozyme is synergistically inhibited by threonine and lysine and is induced by growth in the presence of lysine.
MATERIALS AND METHODS

Materials. [_y-32P]ATP was synthesized by the method of
Johnson and Walseth (10 (17) . The modifications included the use of a charcoal adsorption step as described by Switzer and Gibson (23) and the use of 50 mM 3-(Nmorpholino)propane-sulfonic acid buffer, pH 7.0, in place of triethanolamine buffer. All assay mixes were incubated at 25°C for 15 min in the presence of 10 mM L-aspartate. Aspartokinase I activity was determined by assaying ex-tracts in the presence of 10 mM L-lysine and 10 mM L-threonine. Aspartokinase II was assayed with the addition of 10 mM diaminopimelic acid and 20 mM L-threonine. Aspartokinase III activity was quantitated by assaying samples in the presence of 10 mM diaminopimelic acid and subtracting the amount of activity due to aspartokinase II. One unit of aspartokinase activity is defined as the amount of enzyme that catalyzes the production of 1 ,umol of acylphosphate in 30 min under these conditions. Protein determination was performed by the biuret method (12) .
Purification of anti-aspartokinase II IgG. Anti-aspartokinase II antibodies were raised in rabbits by multiple subcutaneous injections of highly purified recombinant aspartokinase II as the antigen (Cocalico Biologicals). Crude serum was obtained from Cocalico Biologicals, where the antiserum was raised in rabbits from highly purified aspartokinase II provided by our laboratory, and was treated with 1 mM phenylmethylsulfonyl fluoride and 1 mM N-tosyl-L-lysine chloromethylketone prior to purification of immunoglobulin G (IgG). Anti-aspartokinase IgG was purified by the method described previously (13) . Additional (5) . A crude extract of strain VS11 cells which had been grown on BMM plus lysine (50 ,ug/ml) was analyzed by gel filtration on Sephacryl S-200 (Fig. 1) . Two peaks of aspartokinase activity were eluted. The first activity peak eluted at a position corresponding to an Mr of greater than 200,000. The activity in this peak was inhibited by 10 mM diaminopimelate but not by 10 mM lysine plus 10 mM threonine. This activity corresponds to the properties of aspartokinase I as described previously (20) . The a Strain 168 was grown on BMM with only tryptophan added; strain VS11 was grown on BMM plus 50 ,ug of lysine per ml. Crude extracts from each were chromatographed on Sephacryl S-200 as described for Fig. 1 and 2 , and fractions corresponding to the aspartokinase activity peak of Mr 120,000 (i.e., excluding aspartokinase I) were pooled and assayed under standard conditions.
b An amount of anti-aspartokinase 1I antibody (2.7 mg) sufficient to inhibit 0.8 U of purified enzyme by 95% was added, and the samples were incubated for 1 h at 25°C prior to assay. from B. subtilis 168. An extract of B. subtilis 168 cells which had been grown on BMM without amino acids (except tryptophan) was also analyzed by chromatography on Sephacryl S-200 (Fig. 2) . Aspartokinase I eluted first, as with extracts of VS11 cells; this activity was completely inhibited by diaminopimelate and insensitive to lysine plus threonine. A second peak of aspartokinase activity eluted at a position equivalent to Mr 120,000; this activity was inhibited by lysine plus threonine and insensitive to diaminopimelate. Immunoblot analysis showed a close correspondence between the Thawed cells of B. subtilis LC168 were broken and centrifuged as described in Materials and Methods. A 2.5-ml sample (25 mg/ml) was applied and chromatographed as described in the legend to Fig.  1 . Fractions (1.0 ml) were collected and assayed for aspartokinase activity in the absence of added inhibitor (0), in the presence of 10 mM diaminopimelate (A), and in the presence of 10 mM L-lysine plus 10 mM L-threonine (LI). Fractions were immunoblotted as described in Materials and Methods, and the radioactivity corresponding to the aspartokinase Il a subunit was plotted (*). Absorbance of fractions at 280 nm. (Table  1) . This fraction from strain VS11 was insensitive to inhibition by anti-aspartokinase II antibodies. In contrast, an extract of strain 168 grown without amino acids was inhibited 63% by the anti-aspartokinase II antibody, suggesting that aspartokinase II and aspartokinase III were present in a 2-to-1 ratio in these cells. Further experiments (Table 1) indicated that aspartokinase III was inhibited by at least 85% by 20 mM threonine. Aspartokinase II was insensitive to threonine inhibition, as previously shown for the purified enzyme from strain VB217 (14) . The previous conclusion that aspartokinase II was subject to multivalent inhibition by lysine and threonine (20) was probably the result of having studied a mixture of aspartokinases II and III.
The ability to separate aspartokinase III from aspartokinase I by Sephacryl S-200 chromatography and the use of extracts of strain VS11 allowed us to examine the sensitivity of the new isozyme to end product inhibitors (Table 2) . Aspartokinase III was sensitive to inhibition by lysine or threonine alone or, much more significantly, in combinations. Individually, the amino acids threonine and lysine inhibited the isozyme by approximately 50% at concentrations of 4 and 5 mM, respectively. Synergistic inhibition was observed at much lower concentrations of lysine and threonine. A concentration of 0.2 mM lysine plus 0.2 mM threonine inhibited aspartokinase III by approximately 76%, and higher concentrations (1.0 mM each) completely inhibited the enzyme.
Amino acid induction and repression of B. subtilis aspartokinases. B. subtilis 168 was grown to late exponential phase in BMM containing various amino acids at 50 pug/ml each.
The specific activities of aspartokinases I, II, and III were determined by the specific assay procedures described in Materials and Methods, which are based on the preceding observations of their specific inhibitory metabolites. Aspartokinase II was repressed by lysine, whereas aspartokinase b A mixture of the amino acids commonly found in proteins was added at 50 ,ug/ml each.
III was induced under the same growth conditions (Table 3) . Methionine caused a three-fold induction of aspartokinase II and had little effect on aspartokinase III levels. Both aspartokinases II and III were repressed by growth on 20 amino acids. Aspartokinase III levels were found to be significantly lower than aspartokinase II levels except under inducing conditions (growth with lysine). Aspartokinase I levels were essentially invariant under all growth conditions tested. The conclusions based on specific activities of aspartokinase II were confirmed by immunoblot analysis, which demonstrated that aspartokinase II activity levels reflect the Table 4 summarizes observation of the specific activities of aspartokinase isozymes in wild-type B. subtilis grown on BMM. The experiments were conducted with cells grown in the absence of amino acids that affect aspartokinase expression and in cells grown with lysine, which represses aspartokinase II and induces aspartokinase III, to increase the sensitivity of the determination of the activity of the new isozyme. In both cases, aspartokinase II levels rose to a maximum at the end of exponential growth and declined significantly during the stationary phase (the cells were limited for glucose), as has been reported by others (20) . We have shown that the decline in aspartokinase II activity is accompanied by parallel decreases in the amount of a and ,B subunits, as measured immunochemically (unpublished experiments). Interestingly, aspartokinase III levels showed a similar pattern of development. In contrast, the specific activity of aspartokinase I was nearly constant in all phases of growth. This result agrees with the observations of others (20) for aspartokinase I.
DISCUSSION
The properties of the three aspartokinase isozymes found in B. subtilis are summarized in Table 5 . The regulatory properties of the newly discovered aspartokinase III, together with those described previously (and confirmed by us) for aspartokinases I and II, allow a rational picture of the overall regulation of the complex aspartyl-,-phosphate pathway to be drawn. Feedback inhibition and repression of aspartokinase II by lysine indicates the importance of this isozyme in control of lysine biosynthesis. Repression of aspartokinase III by threonine and induction of the isozyme by lysine suggest to us that it functions primarily to regulate threonine biosynthesis. It may seem paradoxical that aspartokinase III is induced by lysine and also inhibited by it. However, the concentrations of lysine alone needed to inhibit aspartokinase III (Ki, =5 mM) are much higher than needed to inhibit aspartokinase II (Ki, t0.1 mM [14] ). Only in the presence of threonine does aspartokinase III become inhibitable by physiological levels of lysine. The induction of aspartokinase II by methionine (not previously described by others) may serve to prevent starvation for this amino acid when lysine and threonine are present in excess. Assuming that aspartokinase I is unable to supply precursors to amino acid biosynthesis other than diaminopimelate, excess lysine plus threonine would fully repress aspartokinases II and III and prevent methionine formation unless methionine could antagonize this repression in some manner. Little regulation of aspartokinases by isoleucine has been detected. Perhaps the major regulation of this pathway is at the level of the Aspartokinase I activity is invariant during the exponential and stationary phases of growth and is not altered by addition of amino acids to the growth medium. The role of this isozyme is most likely to provide a constant level of aspartyl-f3-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis, as was proposed earlier (20) . It would be interesting to learn by mutational inactivation of aspartokinases II and III whether aspartokinase I alone is able to supply sufficient precursor for amino acid biosynthesis during rapid growth.
Aspartokinase III apparently escaped detection in earlier studies because it comigrates closely with aspartokinase II on gel filtration chromatography and its levels are quite low in cells grown under many conditions. A key to its discovery was our observation that aspartokinase III is induced by addition of lysine to the growth medium and the repression of aspartokinase II under the same conditions. The availability of a mutant strain, VS11, lacking aspartokinase II activity was also an important tool in demonstrating the existence of the new isozyme. In previous studies, Rosner and Paulus (20) described two aspartokinase isozymes in B. subtilis, which were distinguishable by their molecular weights and sensitivity to inhibitors. One of these was aspartokinase I. Comparison of our findings with the properties of a partially purified fraction called aspartokinase II by Rosner and Paulus indicates that this fraction was largely aspartokinase III, because of its synergistic inhibition by lysine and threonine. Recently it has been found that the B. subtilis strain (ATCC 6051) used by Rosner and Paulus contains very little aspartokinase II and elevated levels of aspartokinase III (H. Paulus, personal communication). Subsequently, Moir and Paulus (14) purified aspartokinase II to homogeneity from an overproducing mutant of B. subtilis, VB217. The properties of the purified enzyme are those which we have ascribed to aspartokinase II in this work.
Lysine-sensitive and lysine-insensitive aspartokinase activities from B. subtilis cells were also described by Hampton et al. (8) . They separated two peaks of activity on a gel filtration column, a result which was similar to the observations of Rosner and Paulus. The larger, lysine-insensitive aspartokinase species was probably aspartokinase I, but was not tested for inhibition by meso-diaminopimelate. The smaller aspartokinase species was inhibited by lysine but contained substantial lysine-insensitive activity, which might have been due to aspartokinase III. However, no inhibition by threonine was observed, as we would have expected. Most of the experiments conducted by Hampton et al. were done with cells grown in the presence of methionine, so the dominant lower-molecular-weight isozyme in the extracts would be expected to be aspartokinase II.
The properties of aspartokinase activities from B. polymyxa (2, (17) (18) (19) , B. brevis (9) , and B. licheniformis (7) have all been described. In each case the observations are suggestive of the presence of two or three isozymes, although they have not always been so interpreted by the authors. In each case it seems to us that a reinvestigation, guided by the collective findings on B. subtilis aspartokinases, might lead to the discovery of one or more new isozymes.
